Browsing by Author Tsironis, L. D.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 2 to 21 of 24 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Effect of a Synthetic Peptide Corresponding to Residues 313 to 320 of the alpha(IIb) Subunit of the Human Platelet Integrin alpha(IIb)beta(3) on Carotid Artery Thrombosis in RabbitsPapamichael, N. D.; Stathopoulou, E. M.; Roussa, V. D.; Tsironis, L. D.; Kotsia, A. P.; Stanica, R. M.; Moussis, V.; Tsikaris, V.; Katsouras, C. S.; Tselepis, A. D.; Michalis, L. K.24-Nov-2015-
Effect Of A Synthetic Peptide Corresponding To Residues 313-320 Of The Aiib Integrin Subunit N Carotid Artery Thrombosis In RabbitsTsikaris, E.; Moussis, V.; Papamichael, N. D.; Roussa, V. D.; Tsironis, L. D.; Kotsia, A. P.; Stanica, R. M.; Katsouras, C. S.; Tselepis, A. D.; Michalis, L. K.24-Nov-2015-
Effect of lipophilic modification of rutin with mono- and poly-unsaturated fatty acids on its antioxidant potencyTsironis, L. D.; Polydera, A.; Stamatis, H.; Tselepis, A. D.24-Nov-2015-
Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolaseTsironis, L. D.; Mitsios, J. V.; Milionis, H. J.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetyllhydrolaseTsironis, L. D.; Mitsios, J. V.; Milionis, H. J.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Efficient enzymatic preparation of hydroxycinnamates in ionic liquids enhances their antioxidant effect on lipoproteins oxidative modificationKatsoura, M. H.; Polydera, A. C.; Tsironis, L. D.; Petraki, M. P.; Rajacic, S. K.; Tselepis, A. D.; Stamatis, H.24-Nov-2015-
Investigation of the role of adjacent amino acids to the 313-320 sequence of the alpha(IIb) subunit on platelet activation and fibrinogen binding to alpha(IIb)beta(3)Mitsios, J. V.; Stamos, G.; Rodis, F. I.; Tsironis, L. D.; Stanica, M. R.; Sakarellos, C.; Tsoukatos, D.; Tsikaris, V.; Tselepis, A. D.24-Nov-2015-
Ionic liquids as media for the biocatalytic preparation of lipophilic derivatives of natural compounds with enhanced antioxidant activityPolydera, A. C.; Tsironis, L. D.; Katsoura, M. H.; Kolisis, F. N.; Tselepis, A. D.; Stamatis, H.24-Nov-2015-
The lipophilic modification of rutin with oleic acid enhances its antioxidant potencyTsironis, L. D.; Polydera, A.; Stamatis, H.; Tselepis, A. D.24-Nov-2015-
The lipophilic modification of the phenolic antioxidant ferulic acid with aliphatic alcohols enhances its antioxidant potencyTsironis, L. D.; Polydera, A.; Stamatis, H.; Tselepis, A. D.24-Nov-2015-
Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: Effect of treatment with levothyroxineMilionis, H. J.; Efstathiadou, Z.; Tselepis, A. D.; Bairaktari, E. T.; Tsironis, L. D.; Tsatsoulis, A.; Elisaf, M. S.24-Nov-2015-
Lipoprotein(a) as a cardiovascular risk factorKatsouras, C. S.; Tsironis, L. D.; Elisaf, M. S.; Goodevenos, J. A.; Michalis, L. K.; Tselepis, A. D.24-Nov-2015-
Lipoprotein(a) inhibits PAF-induced activation of human platelets in a manner independent of the endogenous PAF-acetylhydrolase activityTselepis, A.; Tsironis, L. D.; Mitsios, J. V.; Milionis, H. J.; Elisaf, M.24-Nov-2015-
Lp(a) inhibits PAF-induced activation of the platelet integrin alpha(IIb)beta(3) and fibrinogen bindingMitsios, J. V.; Tsironis, L. D.; Milionis, H. J.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A(2) in atherosclerosis and cardiovascular diseaseTsimikas, S.; Tsironis, L. D.; Tselepis, A. D.24-Nov-2015-
PAF-acetylhydrolase activity on Lp(a) inpatients with acute coronary syndromesTsironis, L. D.; Catsouras, C. S.; Goudevenos, J.; Michalis, L. K.; Sideris, D. A.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Platelet-activating factor (PAF) and PAF-acetylhydrolase activity are secreted from human platelets mainly associated with platelet derived microparticlesMitsios, J. V.; Tsironis, L. D.; Tselepis, A. D.24-Nov-2015-
Platelet-derived microparticles inhibit the oxidative modification of LDL possibly through their phosphatidylserine and plasmalogen contentMitsios, J. V.; Tsironis, L. D.; Dimitriou, A. A.; Tselepis, A. D.24-Nov-2015-
Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery diseaseTsironis, L. D.; Katsouras, C. S.; Lourida, E. S.; Mitsios, J. V.; Goudevenos, J.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart diseaseKatsouras, C. S.; Karabina, S. A.; Tambaki, A. P.; Goudevenos, J. A.; Michalis, L. K.; Tsironis, L. D.; Stroumbis, C. S.; Elisaf, M. S.; Sideris, D. A.; Tselepis, A. D.24-Nov-2015-